View all available purchase options and get full access to this article. This Q&A is derived from recommendations in Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with ...

Current demographic-specific cancer incidence rates were calculated using the Surveillance Epidemiology and End Results database. Population projections from the Census Bureau were used to project ...

1 Patients in the pooled chemo-IO and IO-only arms. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia ...

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure The median survival time and 5-year survival rates were 20.5, 19.8, and 22.0 months and 17.5%, 17.8%, ...

PATIENTS AND METHODS: All patients undergoing radical cystectomy with bilateral pelvic iliac lymphadenectomy, with the intent to cure, for transitional-cell carcinoma of the bladder between July 1971 ...

View all available purchase options and get full access to this article. Supported by Award No. R01CA139118 (A.T.) and Award No. P50CA08393 (A.T.) from the National Cancer Institute. Also supported by ...

We evaluated physical activity in relation to overall and PCa mortality among 2,705 men in the Health Professionals Follow-Up Study diagnosed with nonmetastatic PCa observed from 1990 to 2008.

Quality improvement scorecards driving innovation and best practice in a large community oncology practice.

Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008 Flow cytometry of peripheral blood lymphocytes revealed dramatic efflux of ...

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial Using the National Cancer ...

Circulating Tumor DNA for Minimal Residual Disease in Colon Cancer: Ready for Prime Time? The following represents disclosure information provided by authors of this manuscript. All relationships are ...